# A Phase 1 Study of S-4321

> **NCT06877611** · PHASE1 · RECRUITING · sponsor: **Seismic Therapeutic AU Pty Ltd** · enrollment: 96 (estimated)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** S-4321
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06877611
- **Lead sponsor:** Seismic Therapeutic AU Pty Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-03
- **Primary completion:** 2026-04
- **Final completion:** 2026-04
- **Target enrollment:** 96 (ESTIMATED)
- **Last updated:** 2025-04-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06877611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06877611, "A Phase 1 Study of S-4321". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06877611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*